Search
Entrada Therapeutics Inc
TRDAAdd to Watchlist
5.824USD
-0.226-3.74%
Market hours （ET）Quotes delayed by 15 min
220.96MMarket Cap
LossP/E TTM
TRDA Financials
See Entrada Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Entrada Therapeutics Inc Earnings Date
Latest Release
May 7, 2026
EPS / Forecast
-0.95/-1.04
Revenue / Forecast
875.00K/1.39M
Period
FY2025 Earnings
Revenue(YoY)
25.42M
-87.94%
EPS(YoY)
-3.47
-297.52%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its total revenue reached 25.42M, with a year-on-year change of 210.78M.
What are the current assets of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its current assets were 306.25M, with a year-on-year change of -30.40.
What are the total assets of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its total assets of Entrada Therapeutics Inc were 377.38M, with a year-on-year change of -28.30.
What are the total liabilities of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its total liabilities of Entrada Therapeutics Inc were 71.25M, with a year-on-year change of -27.04.
What is the total equity of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its total equity of Entrada Therapeutics Inc was 306.13M, with a year-on-year change of -28.59.
What is the net operating income of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its net operating income of Entrada Therapeutics Inc was -157.90M, with a year-on-year change of -435.87.
What is the net investment of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its net investment of Entrada Therapeutics Inc was 116.81M, with a year-on-year change of 520.20.
What is the net financing of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its net financing of Entrada Therapeutics Inc was 887.00K, with a year-on-year change of -99.14.
What is the Earnings Per Share (EPS) of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.47, with a year-on-year change of -297.52.
What is the net income of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its net income was -143.75M, with a year-on-year change of -319.04.
What is the net margin of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its net profit margin was -565.48, with a year-on-year change of -1916.24.
What is the Return on Equity (ROE) of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -39.13, with a year-on-year change of -300.03.
What is the Return on Assets (ROA) of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -31.81, with a year-on-year change of -341.30.
What is the operating profit of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2025 earnings report, its operating profit was -157.90M, with a year-on-year change of -435.87.